Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-27T05:08:56.810Z Has data issue: false hasContentIssue false

The New Great Imitator – Neuropsychiatric Symptoms of Lyme Disease

Published online by Cambridge University Press:  23 March 2020

M.C. Cochat Costa Rodrigues
Affiliation:
Magalhães Lemos Hospital, Psychiatry, Porto, Portugal
I. Moreira
Affiliation:
Hospital D.ª Estefânia, Centro Hospitalar de Lisboa Central, Department of Child and Adolescent Psychiatry, Lisboa, Portugal
M.J. Peixoto
Affiliation:
Centro Hospitalar de São João, Clinic of Psychiatry and Mental Health, Porto, Portugal
C. Silveira
Affiliation:
Centro Hospitalar de São João, Clinic of Psychiatry and Mental Health, Porto, Portugal

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Lyme disease, caused by the spirochete Borrelia burgdorferri as recognized as a possible cause of multisystemic signals and symptoms, including symptomatology of the central as well as the peripheral nervous system.

Objectives

Identification of neuropsychiatric symptoms associated with Lyme disease.

Methods

Literature review in the light of researched articles published in Pubmed/Medline as well as related bibliography.

Results

Since the identification of the etiology of syphilis in the early twentieth century, mental health professionals consider the fact that serious psychiatric symptoms can be caused by infections of the central nervous system and that early antibiotic treatment can prevent permanent neurological/psychiatric damage. Syphilis was known as “the great imitator” because its multiple manifestations mimic other known diseases. In recent years, a new epidemic, also with multiple manifestations emerged–Lyme disease, also known as the “new great imitator”. Like syphilis, Lyme disease may be associated with neuropsychiatric symptoms, which means that often these cases are initially referred for psychiatric services, before another diagnosis is made. The incorrect assessment of these patients as individuals with functional psychiatric disease can result in a delay in the start of antibiotic treatment and may cause serious neurological and psychiatric damage.

Conclusions

According to the review, the authors propose that in the evaluation of acute psychiatric disease or atypical chronic disease, with poor therapeutic response, Lyme disease should be considered and ruled out, especially if there is epidemiological context and absence of psychiatric family antecedents.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
e-poster walk: Consultation liaison psychiatry and psychosomatics–Part 1
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.